Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen deprivation therapy for prostate cancer.

Anteris Technologies plans a US$200 million public raising and US$90 million placement to fund development of its artificial heart valve. ... Read More The post Health Check: Ticker device giant backs ...

A step-by-step, evidence-informed framework for interpreting high coronary calcium CT results, refining cardiovascular risk, and implementing integrative pr ...

With cardiovascular disease remaining the leading cause of death in the United States, this Heart Month (February), FIU is establishing an interdisciplinary center designed to accelerate breakthroughs ...